Literature DB >> 19910046

Up-regulation of Cx43 expression and GJIC function in acute leukemia bone marrow stromal cells post-chemotherapy.

Yao Liu1, Xi Zhang, Zhong-jun Li, Xing-hua Chen.   

Abstract

Gap junction intercellular communication (GJIC) among bone marrow stromal cells (BMSCs) most frequently occurs through a channel composed of connexin43 (Cx43). Dysregulation of connexin expression is believed to have a role in carcinogenesis. In earlier work, we found that in acute leukemia BMSCs, expression of Cx43 and functioning GJIC declined. However, there has been no evaluation of whether GJIC in BMSCs in complete remission (CR) post-chemotherapy is different from GJIC pre-chemotherapy. We studied Cx43 expression and tested GJIC function in human bone marrow cultures under different physiological and pathological conditions. To assay Cx43 expression we used immunocytochemistry, laser scan confocal microscopy (LSCM), flow cytometry and RT-PCR. The results showed that the expression level of Cx43 and its mRNA in acute leukemia BMSCs post-chemotherapy was significantly higher and similar to normal levels than in primary acute leukemia BMSCs (p<0.01). Functional tests in cultures using dye transfer and fluorescence recovery after photobleaching (FRAP) assays showed that the function of GJIC in acute leukemia BMSCs was significantly improved following effective chemotherapy. Our findings suggest Cx43 and GJIC might be involved in the courses of occurrence, development and termination of acute leukemia, and effective chemotherapy could improve Cx43 expression and GJIC function that were dysfunctional prior to treatment. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910046     DOI: 10.1016/j.leukres.2009.10.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Expression of connexin 32 and connexin 43 in acute myeloid leukemia and their roles in proliferation.

Authors:  Sha Yi; Yan Chen; Lu Wen; Lijing Yang; Guohui Cui
Journal:  Oncol Lett       Date:  2012-08-29       Impact factor: 2.967

2.  Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor.

Authors:  Marilyn M Bui; Gang Han; Geza Acs; Damon Reed; Ricardo J Gonzalez; T L Pasha; Paul J Zhang
Journal:  Sarcoma       Date:  2011-05-08

3.  Connexin expression in human acute myeloid leukemia cells: identification of patient subsets based on protein and global gene expression profiles.

Authors:  Håkon Reikvam; Anita Ryningen; Lars Rune Sæterdal; Ina Nepstad; Brynjar Foss; Øystein Bruserud
Journal:  Int J Mol Med       Date:  2014-12-19       Impact factor: 4.101

4.  Increased expression of CX43 on stromal cells promotes leukemia apoptosis.

Authors:  Shijie Yang; Qin Wen; Yao Liu; Cheng Zhang; Maihong Wang; Guo Chen; Yi Gong; Jiangjian Zhong; Xuelian Chen; Andres Stucky; Jiang F Zhong; Xi Zhang
Journal:  Oncotarget       Date:  2015-12-29

5.  Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks.

Authors:  Jennifer Enciso; Hector Mayani; Luis Mendoza; Rosana Pelayo
Journal:  Front Physiol       Date:  2016-08-19       Impact factor: 4.566

6.  Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.

Authors:  Kazem Zibara; Jerome Bourgeais; Marwan El-Sabban; Olivier Herault; Farah Kouzi; Frederic Picou; Nathalie Gallay; Julie Brossaud; Hassan Dakik; Benjamin Roux; Sophie Hamard; Louis-Romee Le Nail; Rita Hleihel; Amelie Foucault; Noemie Ravalet; Florence Rouleux-Bonnin; Fabrice Gouilleux; Frederic Mazurier; Marie C Bene; Haidar Akl; Emmanuel Gyan; Jorge Domenech
Journal:  Oncogene       Date:  2019-10-24       Impact factor: 9.867

7.  All-trans retinoic acid arrests cell cycle in leukemic bone marrow stromal cells by increasing intercellular communication through connexin 43-mediated gap junction.

Authors:  Yao Liu; Qin Wen; Xue-Lian Chen; Shi-Jie Yang; Lei Gao; Li Gao; Cheng Zhang; Jia-Li Li; Xi-Xi Xiang; Kai Wan; Xing-Hua Chen; Xi Zhang; Jiang-Fan Zhong
Journal:  J Hematol Oncol       Date:  2015-10-07       Impact factor: 17.388

8.  Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats.

Authors:  Jun-Won Yun; Euna Kwon; Yun-Soon Kim; Seung-Hyun Kim; Ji-Ran You; Hyoung-Chin Kim; Jin-Sung Park; Jeong-Hwan Che; Sang-Koo Lee; Ja-June Jang; Hyeon Hoe Kim; Byeong-Cheol Kang
Journal:  BMC Complement Altern Med       Date:  2018-09-12       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.